ProQR Therapeutics N.V (PRQR) Debt to Equity: 2021-2024
- ProQR Therapeutics N.V's Debt to Equity fell 0.21% to $0.10 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.10, marking a year-over-year decrease of 0.21%. This contributed to the annual value of $0.10 for FY2024, which is 99689.12% up from last year.
- Latest data reveals that ProQR Therapeutics N.V reported Debt to Equity of $0.10 as of Q4 2024, which was down 0.21% from $0.10 recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics N.V's Debt to Equity ranged from a high of $0.39 in Q4 2021 and a low of $0.10 during Q4 2022.
- In the last 3 years, ProQR Therapeutics N.V's Debt to Equity had a median value of $0.10 in 2024 and averaged $0.10.
- As far as peak fluctuations go, ProQR Therapeutics N.V's Debt to Equity crashed by 73.72% in 2022, and later increased by 2.12% in 2023.
- ProQR Therapeutics N.V's Debt to Equity (Quarterly) stood at $0.39 in 2021, then tumbled by 73.72% to $0.10 in 2022, then rose by 2.12% to $0.10 in 2023, then declined by 0.21% to $0.10 in 2024.
- Its last three reported values are $0.10 in Q4 2024, $0.10 for Q4 2023, and $0.10 during Q4 2022.
